Results 151 to 160 of about 462,228 (311)

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Enhancing Transformer-Based Language Models for Hungarian Handwritten Text Recognition. [PDF]

F1000Res
Al-Hitawi MAS, Gyöngyössy NM.
europepmc   +1 more source

The nature of the Internet [PDF]

, 2004
Hungarian Civil Liberties Union
core  

Repo Markets - Experiences and opportunities in Hungary [PDF]

More and more questions have arisen recently in the National Bank of Hungary about repo markets. The topic came into the lime light with the latest changes of monetary policy instruments.
Dániel Szakály, Henrik Tóth
core  

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

From Cookbooks to Networks: A Framework for Comparing Multiethnic Ingredient Systems in Transylvania. [PDF]

Foods
Magyari-Sáska Z, Magyari-Sáska A, Bálint-Bálint L.   +2 more
europepmc   +1 more source

Ocrelizumab‐induced colitis: VigiBase disproportionality analysis, case reports and literature review

British Journal of Clinical Pharmacology, EarlyView.
Aims Ocrelizumab is a humanized anti‐CD20 monoclonal antibody used in multiple sclerosis. Since its commercialization, several cases of ocrelizumab‐induced colitis have been reported in the scientific literature. Methods To explore the potential association of ocrelizumab with colitis as an adverse drug reaction (ADR), we conducted a descriptive and ...
Audrey Fresse, Christophe Hommel, Nadine Petitpain, Philippe Kerschen   +3 more
wiley   +1 more source

Hungary's Current Climate Conditions Converge With the North-Mediterranean of the 1980s: A Case Study in Mediterranean Ant Species New to Hungary. [PDF]

Ecol Evol
Csősz S, Laczi M, Herczeg G, Báthori F.   +3 more
europepmc   +1 more source

Comparative efficacy of GLP‐1 RA, tirzepatide and SGLT‐2 inhibitors in metabolic liver disease: A network meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aim Metabolic liver disease, including nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis, is a major cause of chronic liver dysfunction worldwide, creating an urgent need for effective treatments. This systematic literature review (SLR) and network meta‐analysis (NMA) systematically reviews and compares the efficacy and safety ...
Andrej Belančić, Christina Antza, Anastasios Poutachidis, Smaro Palaska, Elvira Meni Maria Gkrinia, Andrea Katrin Faour, Yusuf Ziya Sener, Seher Sener, Rehena Sultana   +8 more
wiley   +1 more source

Climate-driven decline of Norway spruce in Central Europe: a threshold crossing in the warming Carpathian Basin. [PDF]

Int J Biometeorol
Lisztes-Szabó Z, Tóth A, Filep AF, Szentes O, László E, Braun M.   +5 more
europepmc   +1 more source